Macaque-tropic human immunodeficiency virus type 1: Breaking out of the host restriction factors

Frontiers in Microbiology

Volumn 4, Issue JUL, 2013, Pages

  Saito, Akatsuki ^a,b   Akari, Hirofumi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b The Japan Foundation   (Japan)

Author keywords

Animal model; Genetic background; HIV 1; Host factors; Macaques

Indexed keywords

ALPHA1 INTERFERON; ANTIGEN; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3F; BETA INTERFERON; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; CYCLOSPORIN A; HOST RESTRICTION FACTOR; TRIPARTITE MOTIF PROTEIN 5; UNCLASSIFIED DRUG;

DNA POLYMORPHISM; GENE MUTATION; GENE REPLICATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNIZATION; MACACA; NONHUMAN; PATHOGENICITY; PHOSPHORYLATION; REVIEW; SEQUENCE ANALYSIS; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 84885363041     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2013.00187     Document Type: Review

References (184)

1. Agy, M. B., Frumkin, L. R., Corey, L., Coombs, R. W., Wolinsky, S. M., Koehler, J., et al. (1992). Infection of Macaca nemestrina by human immunodeficiency virus type-1. Science 257, 103-106. doi: 10.1126/science.1621083
2. Agy, M. B., Schmidt, A., Florey, M. J., Kennedy, B. J., Schaefer, G., Katze, M. G., et al. (1997). Serial in vivo passage of HIV-1 infection in Macaca nemestrina. Virology 238, 336-343. doi: 10.1006/viro.1997.8832
3. Akiyama, H., Ishimatsu, M., Miura, T., Hayami, M., and Ido, E. (2008). Construction and infection of a new simian/human immunodeficiency chimeric virus (SHIV) containing the integrase gene of the human immunodeficiency virus type 1 genome and analysis of its adaptation to monkey cells. Microbes Infect. 10, 531-539. doi: 10.1016/j.micinf.2008.02.001
4. Alexander, L., Illyinskii, P. O., Lang, S. M., Means, R. E., Lifson, J., Mansfield, K., et al. (2003). Determinants of increased replicative capacity of serially passaged simian immunodeficiency virus with nef deleted in rhesus monkeys. J. Virol. 77, 6823-6835. doi: 10.1128/JVI.77.12.6823-6835.2003
5. Alter, H. J., Eichberg, J. W., Masur, H., Saxinger, W. C., Gallo, R., Macher, A. M., et al. (1984). Transmission of HTLV-III infection from human plasma to chimpanzees: an animal model for AIDS. Science 226, 549-552. doi: 10.1126/science.6093251
6. Amara, R. R., Villinger, F., Altman, J. D., Lydy, S. L., O'Neil, S. P., Staprans, S. I., et al. (2001). Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 292, 69-74. doi: 10.1126/science.1058915
7. Ambrose, Z., Boltz, V., Palmer, S., Coffin, J. M., Hughes, S. H., and Kewalramani, V. N. (2004). In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques. J. Virol. 78, 13553-13561. doi: 10.1128/JVI.78.24.13553-13561.2004
8. Asaoka, K., Ikeda, K., Hishinuma, T., Horie-Inoue, K., Takeda, S., and Inoue, S. (2005). A retrovirus restriction factor TRIM5alpha is transcriptionally regulated by interferons. Biochem. Biophys. Res. Commun. 338, 1950-1956. doi: 10.1016/j.bbrc.2005.10.173
9. Atchison, R. E., Gosling, J., Monteclaro, F. S., Franci, C., Digilio, L., Charo, I. F., et al. (1996). Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines. Science 274, 1924-1926. doi: 10.1126/science.274.5294.1924
10. Baba, T. W., Liska, V., Hofmann-Lehmann, R., Vlasak, J., Xu, W., Ayehunie, S., et al. (2000). Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat. Med. 6, 200-206. doi: 10.1038/72309
11. Baldauf, H. M., Pan, X., Erikson, E., Schmidt, S., Daddacha, W., Burggraf, M., et al. (2012). SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells. Nat. Med. 18, 1682-1687. doi: 10.1038/nm.2964
12. Barouch, D. H., Santra, S., Kuroda, M. J., Schmitz, J. E., Plishka, R., Buckler-White, A., et al. (2001). Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination. J. virol. 75, 5151-5158. doi: 10.1128/JVI.75.11.5151-5158.2001
13. Belshan, M., Kimata, J. T., Brown, C., Cheng, X., Mcculley, A., Larsen, A., et al. (2012). Vpx is critical for SIVmne infection of pigtail macaques. Retrovirology 9, 32. doi: 10.1186/1742-4690-9-32
14. Berger, A., Sommer, A. F., Zwarg, J., Hamdorf, M., Welzel, K., Esly, N., et al. (2011). SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutieres syndrome are highly susceptible to HIV-1 infection. PLoS Pathog. 7:e1002425. doi: 10.1371/journal.ppat.1002425
15. Berges, B. K., and Rowan, M. R. (2011). The utility of the new generation of humanized mice to study HIV-1 infection: transmission, prevention, pathogenesis, and treatment. Retrovirology 8, 65. doi: 10.1186/1742-4690-8-65
16. Berry, N. J., Marzetta, F., Towers, G. J., and Rose, N. J. (2012). Diversity of TRIM5alpha and TRIMCyp sequences in cynomolgus macaques from different geographical origins. Immunogenetics 64, 267-278. doi: 10.1007/s00251-011-0585-x
17. Berthoux, L., Sebastian, S., Sayah, D. M., and Luban, J. (2005). Disruption of human TRIM5alpha antiviral activity by nonhuman primate orthologues. J. Virol. 79, 7883-7888. doi: 10.1128/JVI.79.12.7883-7888.2005
18. Besnier, C., Takeuchi, Y., and Towers, G. (2002). Restriction of lentivirus in monkeys. Proc. Natl. Acad. Sci. U.S.A. 99, 11920-11925. doi: 10.1073/pnas.172384599
19. Bitzegeio, J., Sampias, M., Bieniasz, P. D., and Hatziioannou, T. (2013). Adaptation to the interferon-induced antiviral state by human and simian immunodeficiency viruses. J. Virol. 87, 3549-3560. doi: 10.1128/JVI.03219-12
20. Bomsel, M., Tudor, D., Drillet, A. S., Alfsen, A., Ganor, Y., Roger, M. G., et al. (2011). Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges. Immunity 34, 269-280. doi: 10.1016/j.immuni.2011.01.015
21. Bowie, A. G., and Unterholzner, L. (2008). Viral evasion and subversion of pattern-recognition receptor signaling. Nat. Rev. Immunol. 8, 911-922. doi: 10.1038/nri2436
22. Brennan, G., Kozyrev, Y., and Hu, S. L. (2008). TRIMCyp expression in Old World primates Macaca nemestrina and Macaca fascicularis. Proc. Natl. Acad. Sci. U.S.A. 105, 3569-3574. doi: 10.1073/pnas.0709511105
23. Cafaro, A., Caputo, A., Fracasso, C., Maggiorella, M. T., Goletti, D., Baroncelli, S., et al. (1999). Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine. Nat. Med. 5, 643-650. doi: 10.1038/9488
24. Cocka, L. J., and Bates, P. (2012). Identification of alternatively translated Tetherin isoforms with differing antiviral and signaling activities. PLoS Pathog. 8:e1002931. doi: 10.1371/journal.ppat.1002931
25. Cohen, J. (2007). Animal studies. NIH to end chimp breeding for research. Science 316, 1265. doi: 10.1126/science.316.5829.1265
26. Conticello, S. G., Harris, R. S., and Neuberger, M. S. (2003). The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G. Curr. Biol. 13, 2009-2013. doi: 10.1016/j.cub.2003.10.034
27. Courgnaud, V., Abela, B., Pourrut, X., Mpoudi-Ngole, E., Loul, S., Delaporte, E., et al. (2003). Identification of a new simian immunodeficiency virus lineage with a vpu gene present among different cercopithecus monkeys (C. mona, C. cephus, and C. nictitans) from Cameroon. J. Virol. 77, 12523-12534. doi: 10.1128/JVI.77.23.12523-12534.2003
28. Cowan, S., Hatziioannou, T., Cunningham, T., Muesing, M. A., Gottlinger, H. G., and Bieniasz, P. D. (2002). Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism. Proc. Nat. Acad. Sci. U.S.A. 99, 11914-11919. doi: 10.1073/pnas.162299499
29. Crow, Y. J., and Rehwinkel, J. (2009). Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity. Hum. Mol. Genet. 18, R130-R136. doi: 10.1093/hmg/ddp293
30. Daniel, M. D., Kirchhoff, F., Czajak, S. C., Sehgal, P. K., and Desrosiers, R. C. (1992). Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258, 1938-1941. doi: 10.1126/science.1470917
31. Daniel, M. D., Letvin, N. L., King, N. W., Kannagi, M., Sehgal, P. K., Hunt, R. D., et al. (1985). Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science 228, 1201-1204. doi: 10.1126/science.3159089
32. Dazza, M. C., Ekwalanga, M., Nende, M., Shamamba, K. B., Bitshi, P., Paraskevis, D., et al. (2005). Characterization of a novel vpu-harboring simian immunodeficiency virus from a Dent's Mona monkey (Cercopithecus mona denti). J. Virol. 79, 8560-8571. doi: 10.1128/JVI.79.13.8560-8571.2005
33. De Groot, N. G., Heijmans, C. M., Koopman, G., Verschoor, E. J., Bogers, W. M., and Bontrop, R. E. (2011). TRIM5 allelic polymorphism in macaque species/populations of different geographic origins: its impact on SIV vaccine studies. Tissue Antigens 78, 256-262. doi: 10.1111/j.1399-0039.2011.01768.x
34. Denton, P. W., Estes, J. D., Sun, Z., Othieno, F. A., Wei, B. L., Wege, A. K., et al. (2008). Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice. PLoS Med. 5, e16. doi: 10.1371/journal.pmed.0050016
35. Denton, P. W., Olesen, R., Choudhary, S. K., Archin, N. M., Wahl, A., Swanson, M. D., et al. (2012). Generation of HIV latency in humanized BLT mice. J. Virol. 86, 630-634. doi: 10.1128/JVI.06120-11
36. Descours, B., Cribier, A., Chable-Bessia, C., Ayinde, D., Rice, G., Crow, Y., et al. (2012). SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4(+) T-cells. Retrovirology 9, 87. doi: 10.1186/1742-4690-9-87
37. De Silva, S., and Wu, L. (2011). TRIM5 acts as more than a retroviral restriction factor. Viruses 3, 1204-1209. doi: 10.3390/v3071204
38. Dietrich, E. A., Brennan, G., Ferguson, B., Wiseman, R. W., O'Connor, D., and Hu, S. L. (2011). Variable prevalence and functional diversity of the antiretroviral restriction factor TRIMCyp in Macaca fascicularis. J. Virol. 85, 9956-9963. doi: 10.1128/JVI.00097-11
39. Erikson, E., Adam, T., Schmidt, S., Lehmann-Koch, J., Over, B., Goffinet, C., et al. (2011). In vivo expression profile of the antiviral restriction factor and tumor-targeting antigen CD317/BST-2/HM1.24/tetherin in humans. Proc. Natl. Acad. Sci. U.S.A. 108, 13688-13693. doi: 10.1073/pnas.1101684108
40. Feinberg, M. B., and Moore, J. P. (2002). AIDS vaccine models: challenging challenge viruses. Nat. Med. 8, 207-210. doi: 10.1038/nm0302-207
41. Filice, G., Cereda, P. M., and Varnier, O. E. (1988). Infection of rabbits with human immunodeficiency virus. Nature 335, 366-369. doi: 10.1038/335366a0
42. Fultz, P. N., Mcclure, H. M., Swenson, R. B., Mcgrath, C. R., Brodie, A., Getchell, J. P., et al. (1986). Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome. J. Virol. 58, 116-124.
43. Fultz, P. N., Siegel, R. L., Brodie, A., Mawle, A. C., Stricker, R. B., Swenson, R. B., et al. (1991). Prolonged CD4+ lymphocytopenia and thrombocytopenia in a chimpanzee persistently infected with human immunodeficiency virus type 1. J. Infect. Dis. 163, 441-447. doi: 10.1093/infdis/163.3.441
44. Fultz, P. N., Srinivasan, A., Greene, C. R., Butler, D., Swenson, R. B., and Mcclure, H. M. (1987). Superinfection of a chimpanzee with a second strain of human immunodeficiency virus. J. Virol. 61, 4026-4029.
45. Fultz, P. N., Wei, Q., and Yue, L. (1999). Rectal transmission of human immunodeficiency virus type 1 to chimpanzees. J. Infect. Dis. 179(Suppl. 3), S418-S421. doi: 10.1086/314796
46. Gabuzda, D. H., Lawrence, K., Langhoff, E., Terwilliger, E., Dorfman, T., Haseltine, W. A., et al. (1992). Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes. J. Virol. 66, 6489-6495. doi: 10.1186/1742-4690-9-93
47. Galao, R. P., Le Tortorec, A., Pickering, S., Kueck, T., and Neil, S. J. (2012). Innate sensing of HIV-1 assembly by Tetherin induces NFkappaB-dependent proinflammatory responses. Cell Host Microbe 12, 633-644. doi: 10.1016/j.chom.2012.10.007
48. Gardner, M. B., and Luciw, P. A. (1989). Animal models of AIDS. FASEB J. 3, 2593-2606. doi: 10.1038/nrmicro2911
49. Gautam, R., Nishimura, Y., Lee, W. R., Donau, O., Buckler-White, A., Shingai, M., et al. (2012). Pathogenicity and mucosal transmissibility of the R5-tropic simian/human immunodeficiency virus SHIV(AD8) in rhesus macaques: implications for use in vaccine studies. J. Virol. 86, 8516-8526. doi: 10.1128/JVI.00644-12
50. Gibbs, J. S., Lackner, A. A., Lang, S. M., Simon, M. A., Sehgal, P. K., Daniel, M. D., et al. (1995). Progression to AIDS in the absence of a gene for vpr or vpx. J. Virol. 69, 2378-2383.
51. Goila-Gaur, R., and Strebel, K. (2008). HIV-1 Vif, APOBEC, and intrinsic immunity. Retrovirology 5:51. doi: 10.1186/1742-4690-5-51
52. Goujon, C., Arfi, V., Pertel, T., Luban, J., Lienard, J., Rigal, D., et al. (2008). Characterization of simian immunodeficiency virus SIVSM/human immunodeficiency virus type 2 Vpx function in human myeloid cells. J. Virol. 82, 12335-12345. doi: 10.1128/JVI.01181-08
53. Goujon, C., Riviere, L., Jarrosson-Wuilleme, L., Bernaud, J., Rigal, D., Darlix, J. L., et al. (2007). SIVSM/HIV-2 Vpx proteins promote retroviral escape from a proteasome-dependent restriction pathway present in human dendritic cells. Retrovirology 4, 2. doi: 10.1186/1742-4690-4-2
54. Gramberg, T., Kahle, T., Bloch, N., Wittmann, S., Müllers, E., Daddacha, W., et al. (2013). Restriction of diverse retroviruses by SAMHD1. Retrovirology 10, 26. doi: 10.1186/1742-4690-10-26
55. Gupta, R. K., Mlcochova, P., Pelchen-Matthews, A., Petit, S. J., Mattiuzzo, G., Pillay, D., et al. (2009). Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration. Proc. Natl. Acad. Sci. U.S.A. 106, 20889-20894. doi: 10.1073/pnas.0907075106
56. Harouse, J. M. (1999). Distinct Pathogenic Sequela in Rhesus Macaques Infected with CCR5 or CXCR4 Utilizing SHIVs. Science 284, 816-819. doi: 10.1126/science.284.5415.816
57. Hatziioannou, T., Ambrose, Z., Chung, N. P., Piatak, M. Jr., Yuan, F., Trubey, C. M., et al. (2009). A macaque model of HIV-1 infection. Proc. Natl. Acad. Sci. U.S.A. 106, 4425-4429. doi: 10.1073/pnas.0812587106
58. Hatziioannou, T., Perez-Caballero, D., Yang, A., Cowan, S., and Bieniasz, P. D. (2004). Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha. Proc. Natl. Acad. Sci. U.S.A. 101, 10774-10779. doi: 10.1073/pnas.0402361101
59. Hatziioannou, T., Princiotta, M., Piatak, M. Jr., Yuan, F., Zhang, F., Lifson, J. D., et al. (2006). Generation of simian-tropic HIV-1 by restriction factor evasion. Science 314, 95. doi: 10.1126/science.1130994
60. Hirsch, V. M., Sharkey, M. E., Brown, C. R., Brichacek, B., Goldstein, S., Wakefield, J., et al. (1998). Vpx is required for dissemination and pathogenesis of SIV(SM) PBj: evidence of macrophage-dependent viral amplification. Nat. Med. 4, 1401-1408. doi: 10.1038/3992
61. Ho, S. H., Shek, L., Gettie, A., Blanchard, J., and Cheng-Mayer, C. (2005). V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques. J. Virol. 79, 12296-12303. doi: 10.1128/JVI.79.19.12296-12303.2005
62. Hofmann, H., Logue, E. C., Bloch, N., Daddacha, W., Polsky, S. B., Schultz, M. L., et al. (2012). The Vpx lentiviral accessory protein targets SAMHD1 for degradation in the nucleus. J. Virol. 86, 12552-12560. doi: 10.1128/JVI.01657-12
63. Hofmann, W., Schubert, D., LaBonte, J., Munson, L., Gibson, S., Scammell, J., et al. (1999). Species-specific, postentry barriers to primate immunodeficiency virus infection. J. Virol. 73, 10020-10028. doi: 10.1038/nature02343
64. Hrecka, K., Hao, C., Gierszewska, M., Swanson, S. K., Kesik-Brodacka, M., Srivastava, S., et al. (2011). Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 474, 658-661. doi: 10.1038/nature10195
65. Hultquist, J. F., Binka, M., Larue, R. S., Simon, V., and Harris, R. S. (2012). Vif proteins of human and simian immunodeficiency viruses require cellular CBFbeta to degrade APOBEC3 restriction factors. J. Virol. 86, 2874-2877. doi: 10.1128/JVI.06950-11
66. Humes, D., Emery, S., Laws, E., and Overbaugh, J. (2012). A species-specific amino acid difference in the macaque CD4 receptor restricts replication by global circulating HIV-1 variants representing viruses from recent infection. J. Virol. 86, 12472-12483. doi: 10.1128/JVI.02176-12
67. Humes, D., and Overbaugh, J. (2011). Adaptation of subtype a human immunodeficiency virus type 1 envelope to pig-tailed macaque cells. J. Virol. 85, 4409-4420. doi: 10.1128/JVI.02244-10
68. Igarashi, T., Ami, Y., Yamamoto, H., Shibata, R., Kuwata, T., Mukai, R., et al. (1997). Protection of monkeys vaccinated with vpr- and/or nef-defective simian immunodeficiency virus strain mac/human immunodeficiency virus type 1 chimeric viruses: a potential candidate live-attenuated human AIDS vaccine. J. Gen. Virol. 78, 985-989. doi: 10.1186/1742-4690-4-66
69. Igarashi, T., Iyengar, R., Byrum, R. A., Buckler-White, A., Dewar, R. L., Buckler, C. E., et al. (2007). Human immunodeficiency virus type 1 derivative with 7% simian immunodeficiency virus genetic content is able to establish infections in pig-tailed macaques. J. Virol. 81, 11549-11552. doi: 10.1128/JVI.00960-07
70. Ito, M., Hiramatsu, H., Kobayashi, K., Suzue, K., Kawahata, M., Hioki, K., et al. (2002). NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100, 3175-3182. doi: 10.1182/blood-2001-12-0207
71. Jager, S., Kim, D. Y., Hultquist, J. F., Shindo, K., Larue, R. S., Kwon, E., et al. (2012). Vif hijacks CBF-beta to degrade APOBEC3G and promote HIV-1 infection. Nature 481, 371-375. doi: 10.1038/nature10693
72. Jarmuz, A., Chester, A., Bayliss, J., Gisbourne, J., Dunham, I., Scott, J., et al. (2002). An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics 79, 285-296. doi: 10.1006/geno.2002.6718
73. Jia, B., Serra-Moreno, R., Neidermyer, W., Rahmberg, A., Mackey, J., Fofana, I. B., et al. (2009). Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2. PLoS Pathog. 5:e1000429. doi: 10.1371/journal.ppat.1000429
74. Johnson, B. K., Stone, G. A., Godec, M. S., Asher, D. M., Gajdusek, D. C., and Gibbs, C. J. Jr. (1993). Long-term observations of human immunodeficiency virus-infected chimpanzees. AIDS Res. Hum. Retroviruses 9, 375-378. doi: 10.1089/aid.1993.9.375
75. Kamada, K., Igarashi, T., Martin, M. A., Khamsri, B., Hatcho, K., Yamashita, T., et al. (2006). Generation of HIV-1 derivatives that productively infect macaque monkey lymphoid cells. Proc. Natl. Acad. Sci. U.S.A. 103, 16959-16964. doi: 10.1073/pnas.0608289103
76. Kao, S., Khan, M. A., Miyagi, E., Plishka, R., Buckler-White, A., and Strebel, K. (2003). The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity. J. Virol. 77, 11398-11407. doi: 10.1128/JVI.77.21.11398-11407.2003
77. Kaushik, R., Zhu, X., Stranska, R., Wu, Y., and Stevenson, M. (2009). A cellular restriction dictates the permissivity of nondividing monocytes/macrophages to lentivirus and gammaretrovirus infection. Cell Host Microbe 6, 68-80. doi: 10.1016/j.chom.2009.05.022
78. Keckesova, Z., Ylinen, L. M., and Towers, G. J. (2004). The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities. Proc. Natl. Acad. Sci. U.S.A. 101, 10780-10785. doi: 10.1073/pnas.0402474101
79. Kestler, H., Kodama, T., Ringler, D., Marthas, M., Pedersen, N., Lackner, A., et al. (1990). Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science 248, 1109-1112. doi: 10.1126/science.2160735
80. Kestler, H. W. III., Ringler, D. J., Mori, K., Panicali, D. L., Sehgal, P. K., Daniel, M. D., et al. (1991). Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65, 651-662. doi: 10.1016/0092-8674(91)90097-I
81. Kidd, J. M., Newman, T. L., Tuzun, E., Kaul, R., and Eichler, E. E. (2007). Population stratification of a common APOBEC gene deletion polymorphism. PLoS Genet. 3:e63. doi: 10.1371/journal.pgen.0030063
82. Kiepiela, P., Ngumbela, K., Thobakgale, C., Ramduth, D., Honeyborne, I., Moodley, E., et al. (2007). CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat. Med. 13, 46-53. doi: 10.1038/nm1520
83. Kirmaier, A., Wu, F., Newman, R. M., Hall, L. R., Morgan, J. S., O'connor, S., et al. (2010). TRIM5 suppresses cross-species transmission of a primate immunodeficiency virus and selects for emergence of resistant variants in the new species. PLoS Biol. 8:e1000462. doi: 10.1371/journal.pbio.1000462
84. Klimkait, T., Strebel, K., Hoggan, M. D., Martin, M. A., and Orenstein, J. M. (1990). The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. J. Virol. 64, 621-629. doi: 10.1016/S1286-4579(03)00191-6
85. Kono, K., Song, H., Shingai, Y., Shioda, T., and Nakayama, E. E. (2008). Comparison of anti-viral activity of rhesus monkey and cynomolgus monkey TRIM5alphas against human immunodeficiency virus type 2 infection. Virology 373, 447-456. doi: 10.1016/j.virol.2007.12.022
86. Kraus, G., Werner, A., Baier, M., Binniger, D., Ferdinand, F. J., Norley, S., et al. (1989). Isolation of human immunodeficiency virus-related simian immunodeficiency viruses from African green monkeys. Proc. Natl. Acad. Sci. U.S.A. 86, 2892-2896. doi: 10.1073/pnas.86.8.2892
87. Kulaga, H., Folks, T., Rutledge, R., Truckenmiller, M. E., Gugel, E., and Kindt, T. J. (1989). Infection of rabbits with human immunodeficiency virus 1. A small animal model for acquired immunodeficiency syndrome. J. Exp. Med. 169, 321-326. doi: 10.1084/jem.169.1.321
88. Kupzig, S., Korolchuk, V., Rollason, R., Sugden, A., Wilde, A., and Banting, G. (2003). Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology. Traffic 4, 694-709. doi: 10.1034/j.1600-0854.2003.00129.x
89. Kuroishi, A., Saito, A., Shingai, Y., Shioda, T., Nomaguchi, M., Adachi, A., et al. (2009). Modification of a loop sequence between alpha-helices 6 and 7 of virus capsid (CA) protein in a human immunodeficiency virus type 1 (HIV-1) derivative that has simian immunodeficiency virus (SIVmac239) vif and CA alpha-helices 4 and 5 loop improves replication in cynomolgus monkey cells. Retrovirology 6, 70. doi: 10.1186/1742-4690-6-70
90. Kwak, Y. T., Ivanov, D., Guo, J., Nee, E., and Gaynor, R. B. (1999). Role of the human and murine cyclin T proteins in regulating HIV-1 tat-activation. J. Mol. Biol. 288, 57-69. doi: 10.1006/jmbi.1999.2664
91. LaBonte, J. A., Babcock, G. J., Patel, T., and Sodroski, J. (2002). Blockade of HIV-1 infection of New World monkey cells occurs primarily at the stage of virus entry. J. Exp. Med. 196, 431-445. doi: 10.1084/jem.20020468
92. Laguette, N., Rahm, N., Sobhian, B., Chable-Bessia, C., Munch, J., Snoeck, J., et al. (2012). Evolutionary and functional analyses of the interaction between the myeloid restriction factor SAMHD1 and the lentiviral Vpx protein. Cell Host Microbe 11, 205-217. doi: 10.1016/j.chom.2012.01.007
93. Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Segeral, E., et al. (2011). SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474, 654-657. doi: 10.1038/nature10117
94. Lahouassa, H., Daddacha, W., Hofmann, H., Ayinde, D., Logue, E. C., Dragin, L., et al. (2012). SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat. Immunol. 13, 223-228. doi: 10.1038/ni.2236
95. Le Tortorec, A., and Neil, S. J. (2009). Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein. J. Virol. 83, 11966-11978. doi: 10.1128/JVI.01515-09
96. Letvin, N. L., Daniel, M. D., Sehgal, P. K., Desrosiers, R. C., Hunt, R. D., Waldron, L. M., et al. (1985). Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science 230, 71-73. doi: 10.1126/science.2412295
97. Letvin, N. L., Montefiori, D. C., Yasutomi, Y., Perry, H. C., Davies, M. E., Lekutis, C., et al. (1997). Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination. Proc. Natl. Acad. Sci. U.S.A. 94, 9378-9383. doi: 10.1073/pnas.94.17.9378
98. Liao, C. H., Kuang, Y. Q., Liu, H. L., Zheng, Y. T., and Su, B. (2007). A novel fusion gene, TRIM5-Cyclophilin A in the pig-tailed macaque determines its susceptibility to HIV-1 infection. AIDS 21(Suppl. 8), S19-S26. doi: 10.1097/01.aids.0000304692.09143.1b
99. Liddament, M. T., Brown, W. L., Schumacher, A. J., and Harris, R. S. (2004). APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo. Curr. Biol. 14, 1385-1391. doi: 10.1016/j.cub.2004.06.050
100. Lim, E. S., Fregoso, O. I., Mccoy, C. O., Matsen, F. A., Malik, H. S., and Emerman, M. (2012). The ability of primate lentiviruses to degrade the monocyte restriction factor SAMHD1 preceded the birth of the viral accessory protein Vpx. Cell Host Microbe 11, 194-204. doi: 10.1016/j.chom.2012.01.004
101. Lusso, P., Markham, P. D., Ranki, A., Earl, P., Moss, B., Dorner, F., et al. (1988). Cell-mediated immune response toward viral envelope and core antigens in gibbon apes (Hylobates lar) chronically infected with human immunodeficiency virus-1. J. Immunol. 141, 2467-2473. doi: 10.1126/science.1621083
102. Madani, N., and Kabat, D. (1998). An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein. J. Virol. 72, 10251-10255. doi: 10.1038/nature00939
103. Maegawa, H., Nakayama, E. E., Kuroishi, A., and Shioda, T. (2008). Silencing of tripartite motif protein (TRIM) 5a mediated anti-HIV-1 activity by truncated mutant of TRIM5a. J. Virol. Methods 151, 249-256. doi: 10.1016/j.jviromet.2008.04.012
104. Mariani, R., Chen, D., Schrofelbauer, B., Navarro, F., Konig, R., Bollman, B., et al. (2003). Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 114, 21-31. doi: 10.1016/S0092-8674(03)00515-4
105. Marsden, M. D., Kovochich, M., Suree, N., Shimizu, S., Mehta, R., Cortado, R., et al. (2012). HIV latency in the humanized BLT mouse. J. Virol. 86, 339-347. doi: 10.1128/JVI.06366-11
106. Matsuda, K., Inaba, K., Fukazawa, Y., Matsuyama, M., Ibuki, K., Horiike, M., et al. (2010). In vivo analysis of a new R5 tropic SHIV generated from the highly pathogenic SHIV-KS661, a derivative of SHIV-89.6. Virology 399, 134-143. doi: 10.1016/j.virol.2010.01.008
107. McCune, J. M. (2001). The dynamics of CD4+ T-cell depletion in HIV disease. Nature 410, 974-979. doi: 10.1038/35073648
108. McNatt, M. W., Zang, T., Hatziioannou, T., Bartlett, M., Fofana, I. B., Johnson, W. E., et al. (2009). Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants. PLoS Pathog. 5, e1000300. doi: 10.1371/journal.ppat.1000300
109. Mehle, A., Strack, B., Ancuta, P., Zhang, C., Mcpike, M., and Gabuzda, D. (2004). Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway. J. Biol. Chem. 279, 7792-7798. doi: 10.1074/jbc. M313093200
110. Melkus, M. W., Estes, J. D., Padgett-Thomas, A., Gatlin, J., Denton, P. W., Othieno, F. A., et al. (2006). Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat. Med. 12, 1316-1322. doi: 10.1038/nm1431
111. Mercenne, G., Bernacchi, S., Richer, D., Bec, G., Henriet, S., Paillart, J. C., et al. (2010). HIV-1 Vif binds to APOBEC3G mRNA and inhibits its translation. Nucleic Acids Res. 38, 633-646. doi: 10.1093/nar/gkp1009
112. Mische, C. C., Javanbakht, H., Song, B., Diaz-Griffero, F., Stremlau, M., Strack, B., et al. (2005). Retroviral restriction factor TRIM5alpha is a trimer. J. Virol. 79, 14446-14450. doi: 10.1128/JVI.79.22.14446-14450.2005
113. Miyagi, E., Brown, C. R., Opi, S., Khan, M., Goila-Gaur, R., Kao, S., et al. (2010). Stably expressed APOBEC3F has negligible antiviral activity. J. Virol. 84, 11067-11075. doi: 10.1128/JVI.01249-10
114. Moldt, B., Rakasz, E. G., Schultz, N., Chan-Hui, P. Y., Swiderek, K., Weisgrau, K. L., et al. (2012). Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo. Proc. Natl. Acad. Sci. U.S.A. 109, 18921-18925. doi: 10.1073/pnas.1214785109
115. Mosier, D. E., Gulizia, R. J., Baird, S. M., and Wilson, D. B. (1988). Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335, 256-259. doi: 10.1038/335256a0
116. Munk, C., Brandt, S. M., Lucero, G., and Landau, N. R. (2002). A dominant block to HIV-1 replication at reverse transcription in simian cells. Proc. Natl. Acad. Sci. U.S.A. 99, 13843-13848. doi: 10.1073/pnas.212400099
117. Naidu, Y. M., Kestler, H. W. III., Li, Y., Butler, C. V., Silva, D. P., Schmidt, D. K., et al. (1988). Characterization of infectious molecular clones of simian immunodeficiency virus (SIVmac) and human immunodeficiency virus type 2: persistent infection of rhesus monkeys with molecularly cloned SIVmac. J. Virol. 62, 4691-4696. doi: 10.1126/science.2160735
118. Nakayama, E. E., and Shioda, T. (2010). Anti-retroviral activity of TRIM5 alpha. Rev. Med. Virol. 20, 77-92. doi: 10.1002/rmv.637
119. Nara, P. L., Robey, W. G., Arthur, L. O., Asher, D. M., Wolff, A. V., Gibbs, C. J. Jr., et al. (1987). Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses. J. Virol. 61, 3173-3180. doi: 10.1007/978-1-4684-5976-0_4
120. Neil, S. J., Sandrin, V., Sundquist, W. I., and Bieniasz, P. D. (2007). An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein. Cell Host Microbe 2, 193-203. doi: 10.1016/j.chom.2007.08.001
121. Neil, S. J., Zang, T., and Bieniasz, P. D. (2008). Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451, 425-430. doi: 10.1038/nature06553
122. Newman, E. N., Holmes, R. K., Craig, H. M., Klein, K. C., Lingappa, J. R., Malim, M. H., et al. (2005). Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity. Curr. Biol. 15, 166-170. doi: 10.1016/j.cub.2004.12.068
123. Newman, R. M., Hall, L., Connole, M., Chen, G. L., Sato, S., Yuste, E., et al. (2006). Balancing selection and the evolution of functional polymorphism in Old World monkey TRIM5alpha. Proc. Natl. Acad. Sci. U.S.A. 103, 19134-19139. doi: 10.1073/pnas.0605838103
124. Newman, R. M., Hall, L., Kirmaier, A., Pozzi, L. A., Pery, E., Farzan, M., et al. (2008). Evolution of a TRIM5-CypA splice isoform in old world monkeys. PLoS Pathog. 4, e1000003. doi: 10.1371/journal.ppat.1000003
125. Nishimura, Y., Igarashi, T., Donau, O. K., Buckler-White, A., Buckler, C., Lafont, B. A., et al. (2004). Highly pathogenic SHIVs and SIVs target different CD4+ T cell subsets in rhesus monkeys, explaining their divergent clinical courses. Proc. Natl. Acad. Sci. U.S.A. 101, 12324-12329. doi: 10.1073/pnas.0404620101
126. Nishimura, Y., Igarashi, T., Haigwood, N., Sadjadpour, R., Plishka, R. J., Buckler-White, A., et al. (2002). Determination of a statistically valid neutralization titer in plasma that confers protection against simian-human immunodeficiency virus challenge following passive transfer of high-titered neutralizing antibodies. J. Virol. 76, 2123-2130. doi: 10.1128/jvi.76.5.2123-2130.2002
127. Nomaguchi, M., Doi, N., Fujiwara, S., Saito, A., Akari, H., Nakayama, E. E., et al. (2013a). Systemic biological analysis of the mutations in two distinct HIV-1mt genomes occurred during replication in macaque cells. Microbes Infect. 15, 319-328. doi: 10.1016/j.micinf.2013.01.005
128. Nomaguchi, M., Yokoyama, M., Kono, K., Nakayama, E. E., Shioda, T., Saito, A., et al. (2013b). Gag-CA Q110D mutation elicits TRIM5-independent enhancement of HIV-1mt replication in macaque cells. Microbes Infect. 15, 56-65. doi: 10.1016/j.micinf.2012.10.013
129. North, T. W., Van Rompay, K. K., Higgins, J., Matthews, T. B., Wadford, D. A., Pedersen, N. C., et al. (2005). Suppression of virus load by highly active antiretroviral therapy in rhesus macaques infected with a recombinant simian immunodeficiency virus containing reverse transcriptase from human immunodeficiency virus type 1. J. Virol. 79, 7349-7354. doi: 10.1128/JVI.79.12.7349-7354.2005
130. Novembre, F. J., Saucier, M., Anderson, D. C., Klumpp, S. A., O'Neil, S. P., Brown, C. R. III., et al. (1997). Development of AIDS in a chimpanzee infected with human immunodeficiency virus type 1. J. Virol. 71, 4086-4091. doi: 10.1089/aid.2007.0182
131. Ohta, Y., Masuda, T., Tsujimoto, H., Ishikawa, K., Kodama, T., Morikawa, S., et al. (1988). Isolation of simian immunodeficiency virus from African green monkeys and seroepidemiologic survey of the virus in various non-human primates. Int. J. Cancer 41, 115-122. doi: 10.1002/ijc.2910410121
132. O'Neil, S. P., Novembre, F. J., Hill, A. B., Suwyn, C., Hart, C. E., Evans-Strickfaden, T., et al. (2000). Progressive infection in a subset of HIV-1-positive chimpanzees. J. Infect. Dis. 182, 1051-1062. doi: 10.1086/315823
133. Perez-Caballero, D., Hatziioannou, T., Yang, A., Cowan, S., and Bieniasz, P. D. (2005). Human tripartite motif 5alpha domains responsible for retrovirus restriction activity and specificity. J. Virol. 79, 8969-8978. doi: 10.1128/JVI.79.14.8969-8978.2005
134. Perron, M. J., Stremlau, M., Song, B., Ulm, W., Mulligan, R. C., and Sodroski, J. (2004). TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells. Proc. Natl. Acad. Sci. U.S.A. 101, 11827-11832. doi: 10.1073/pnas.0403364101
135. Pertel, T., Hausmann, S., Morger, D., Zuger, S., Guerra, J., Lascano, J., et al. (2011). TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 472, 361-365. doi: 10.1038/nature09976
136. Powell, R. D., Holland, P. J., Hollis, T., and Perrino, F. W. (2011). Aicardi-Goutieres syndrome gene and HIV-1 restriction factor SAMHD1 is a dGTP-regulated deoxynucleotide triphosphohydrolase. J. Biol. Chem. 286, 43596-43600. doi: 10.1074/jbc. C111.317628
137. Prince, A. M., Horowitz, B., Baker, L., Shulman, R. W., Ralph, H., Valinsky, J., et al. (1988). Failure of a human immunodeficiency virus (HIV) immune globulin to protect chimpanzees against experimental challenge with HIV. Proc. Natl. Acad. Sci. U.S.A. 85, 6944-6948. doi: 10.1073/pnas.85.18.6944
138. Reimann, K. A., Li, J. T., Veazey, R., Halloran, M., Park, I. W., Karlsson, G. B., et al. (1996). A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys. J. Virol. 70, 6922-6928. doi: 10.1086/512243
139. Reina, S., Markham, P., Gard, E., Rayed, F., Reitz, M., Gallo, R. C., et al. (1993). Serological, biological, and molecular characterization of New Zealand white rabbits infected by intraperitoneal inoculation with cell-free human immunodeficiency virus. J. Virol. 67, 5367-5374. doi: 10.1089/aid.1994.10.285
140. Reymond, A., Meroni, G., Fantozzi, A., Merla, G., Cairo, S., Luzi, L., et al. (2001). The tripartite motif family identifies cell compartments. EMBO J. 20, 2140-2151. doi: 10.1093/emboj/20.9.2140
141. Reynolds, M. R., Sacha, J. B., Weiler, A. M., Borchardt, G. J., Glidden, C. E., Sheppard, N. C., et al. (2011). The TRIM5{alpha} genotype of rhesus macaques affects acquisition of simian immunodeficiency virus SIVsmE660 infection after repeated limiting-dose intrarectal challenge. J. Virol. 85, 9637-9640. doi: 10.1128/JVI.05074-11
142. Rice, G. I., Bond, J., Asipu, A., Brunette, R. L., Manfield, I. W., Carr, I. M., et al. (2009). Mutations involved in Aicardi-Goutieres syndrome implicate SAMHD1 as regulator of the innate immune response. Nat. Genet. 41, 829-832. doi: 10.1038/ng.373
143. Saito, A., Kawamoto, Y., Higashino, A., Yoshida, T., Ikoma, T., Suzaki, Y., et al. (2012a). Allele frequency of antiretroviral host factor TRIMCyp in wild-caught cynomolgus macaques (Macaca fascicularis). Front. Microbiol. 3, 314. doi: 10.3389/fmicb.2012.00314
144. Saito, A., Kono, K., Nomaguchi, M., Yasutomi, Y., Adachi, A., Shioda, T., et al. (2012b). Geographical, genetic and functional diversity of antiretroviral host factor TRIMCyp in cynomolgus macaque (Macaca fascicularis). J. Gen. Virol. 93, 594-602. doi: 10.1099/vir.0.038075-0
145. Saito, A., Nomaguchi, M., Iijima, S., Kuroishi, A., Yoshida, T., Lee, Y. J., et al. (2011). Improved capacity of a monkey-tropic HIV-1 derivative to replicate in cynomolgus monkeys with minimal modifications. Microbes Infect. 13, 58-64. doi: 10.1016/j.micinf.2010.10.001
146. Saito, A., Nomaguchi, M., Kono, K., Iwatani, Y., Yokoyama, M., Yasutomi, Y., et al. (2013). TRIM5 genotypes in cynomolgus monkeys primarily influence inter-individual diversity in susceptibility to monkey-tropic human immunodeficiency virus type 1. J. Gen. Virol. 94, 1318-1324. doi: 10.1099/vir.0.050252-0
147. Sakai, H., Shibata, R., Sakuragi, J., Sakuragi, S., Kawamura, M., and Adachi, A. (1993). Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles. J. Virol. 67, 1663-1666. doi: 10.1128/JVI.75.16.7252-7265.2001
148. Sakai, H., Tokunaga, K., Kawamura, M., and Adachi, A. (1995). Function of human immunodeficiency virus type 1 Vpu protein in various cell types. J. Gen. Virol. 76(Pt 11), 2717-2722. doi: 10.1099/0022-1317-76-11-2717
149. Sakuma, R., Mael, A. A., and Ikeda, Y. (2007). Alpha interferon enhances TRIM5alpha-mediated antiviral activities in human and rhesus monkey cells. J. Virol. 81, 10201-10206. doi: 10.1128/JVI.00419-07
150. Sato, K., Misawa, N., Fukuhara, M., Iwami, S., An, D. S., Ito, M., et al. (2012). Vpu augments the initial burst phase of HIV-1 propagation and downregulates BST2 and CD4 in humanized mice. J. Virol. 86, 5000-5013. doi: 10.1128/JVI.07062-11
151. Sauter, D., Schindler, M., Specht, A., Landford, W. N., Munch, J., Kim, K. A., et al. (2009). Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. Cell Host Microbe 6, 409-421. doi: 10.1016/j.chom.2009.10.004
152. Sayah, D. M., Sokolskaja, E., Berthoux, L., and Luban, J. (2004). Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 430, 569-573. doi: 10.1038/nature02777
153. Schmitt, K., Guo, K., Algaier, M., Ruiz, A., Cheng, F., Qiu, J., et al. (2011). Differential virus restriction patterns of rhesus macaque and human APOBEC3A: implications for lentivirus evolution. Virology 419, 24-42. doi: 10.1016/j.virol.2011.07.017
154. Schrofelbauer, B., Senger, T., Manning, G., and Landau, N. R. (2006). Mutational alteration of human immunodeficiency virus type 1 Vif allows for functional interaction with nonhuman primate APOBEC3G. J. Virol. 80, 5984-5991. doi: 10.1128/JVI.00388-06
155. Schuitemaker, H., Koot, M., Kootstra, N. A., Dercksen, M. W., De Goede, R. E., Van Steenwijk, R. P., et al. (1992). Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J. Virol. 66, 1354-1360. doi: 10.1038/nm0398-346
156. Serra-Moreno, R., Jia, B., Breed, M., Alvarez, X., and Evans, D. T. (2011). Compensatory changes in the cytoplasmic tail of gp41 confer resistance to tetherin/BST-2 in a pathogenic nef-deleted SIV. Cell Host Microbe 9, 46-57. doi: 10.1016/j.chom.2010.12.005
157. Sheehy, A. M., Gaddis, N. C., Choi, J. D., and Malim, M. H. (2002). Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418, 646-650. doi: 10.1038/nature00939
158. Shibata, R., and Adachi, A. (1992). SIV/HIV recombinants and their use in studying biological properties. AIDS Res. Hum. Retroviruses 8, 403-409. doi: 10.1089/aid.1992.8.403
159. Shibata, R., Igarashi, T., Haigwood, N., Buckler-White, A., Ogert, R., Ross, W., et al. (1999). Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys. Nat. Med. 5, 204-210. doi: 10.1038/5568
160. Shibata, R., Kawamura, M., Sakai, H., Hayami, M., Ishimoto, A., and Adachi, A. (1991). Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells. J. Virol. 65, 3514-3520. doi: 10.1128/JVI.77.1.726-731.2003
161. Shibata, R., Sakai, H., Kawamura, M., Tokunaga, K., and Adachi, A. (1995). Early replication block of human immunodeficiency virus type 1 in monkey cells. J. Gen. Virol. 76, 2723-2730. doi: 10.1099/0022-1317-76-11-2723
162. Shingai, M., Yoshida, T., Martin, M. A., and Strebel, K. (2011). Some human immunodeficiency virus type 1 Vpu proteins are able to antagonize macaque BST-2 in vitro and in vivo: Vpu-negative simian-human immunodeficiency viruses are attenuated in vivo. J. Virol. 85, 9708-9715. doi: 10.1128/JVI.00626-11
163. Shultz, L. D., Lyons, B. L., Burzenski, L. M., Gott, B., Chen, X., Chaleff, S., et al. (2005). Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J. Immunol. 174, 6477-6489. doi: 10.3410/f.1003045.323931
164. Simon, J. H., Gaddis, N. C., Fouchier, R. A., and Malim, M. H. (1998). Evidence for a newly discovered cellular anti-HIV-1 phenotype. Nat. Med. 4, 1397-1400. doi: 10.1038/3987
165. Speck, R. F., Penn, M. L., Wimmer, J., Esser, U., Hague, B. F., Kindt, T. J., et al. (1998). Rabbit cells expressing human CD4 and human CCR5 are highly permissive for human immunodeficiency virus type 1 infection. J. Virol. 72, 5728-5734. doi: 10.1186/1742-4690-4-53
166. Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P., and Sodroski, J. (2004). The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427, 848-853. doi: 10.1038/nature02343
167. Tanaka, Y., Marusawa, H., Seno, H., Matsumoto, Y., Ueda, Y., Kodama, Y., et al. (2006). Anti-viral protein APOBEC3G is induced by interferon-alpha stimulation in human hepatocytes. Biochem. Biophys. Res. Commun. 341, 314-319. doi: 10.1016/j.bbrc.2005.12.192
168. Tervo, H. M., and Keppler, O. T. (2010). High natural permissivity of primary rabbit cells for HIV-1, with a virion infectivity defect in macrophages as the final replication barrier. J. Virol. 84, 12300-12314. doi: 10.1128/JVI.01607-10
169. Thippeshappa, R., Polacino, P., Yu Kimata, M. T., Siwak, E. B., Anderson, D., Wang, W., et al. (2011). Vif substitution enables persistent infection of pig-tailed macaques by human immunodeficiency virus type 1. J. Virol. 85, 3767-3779. doi: 10.1128/JVI.02438-10
170. Traggiai, E., Chicha, L., Mazzucchelli, L., Bronz, L., Piffaretti, J. C., Lanzavecchia, A., et al. (2004). Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 304, 104-107. doi: 10.1126/science.1093933
171. Uberla, K., Stahl-Hennig, C., Bottiger, D., Matz-Rensing, K., Kaup, F. J., Li, J., et al. (1995). Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors. Proc. Natl. Acad. Sci. U.S.A. 92, 8210-8214. doi: 10.1073/pnas.92.18.8210
172. Van Damme, N., Goff, D., Katsura, C., Jorgenson, R. L., Mitchell, R., Johnson, M. C., et al. (2008). The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 3, 245-252. doi: 10.1016/j.chom.2008.03.001
173. Virgen, C. A., and Hatziioannou, T. (2007). Antiretroviral activity and Vif sensitivity of rhesus macaque APOBEC3 proteins. J. Virol. 81, 13932-13937. doi: 10.1128/JVI.01760-07
174. Virgen, C. A., Kratovac, Z., Bieniasz, P. D., and Hatziioannou, T. (2008). Independent genesis of chimeric TRIM5-cyclophilin proteins in two primate species. Proc. Natl. Acad. Sci. U.S.A. 105, 3563-3568. doi: 10.1073/pnas.0709258105
175. Wiegand, H. L., Doehle, B. P., Bogerd, H. P., and Cullen, B. R. (2004). A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins. EMBO J. 23, 2451-2458. doi: 10.1038/sj.emboj.7600246
176. Wilson, S. J., Webb, B. L., Ylinen, L. M., Verschoor, E., Heeney, J. L., and Towers, G. J. (2008). Independent evolution of an antiviral TRIMCyp in rhesus macaques. Proc. Natl. Acad. Sci. U.S.A. 105, 3557-3562. doi: 10.1073/pnas.0709003105
177. Wyand, M. S., Manson, K., Montefiori, D. C., Lifson, J. D., Johnson, R. P., and Desrosiers, R. C. (1999). Protection by live, attenuated simian immunodeficiency virus against heterologous challenge. J. Virol. 73, 8356-8363. doi: 10.1371/journal.pone.0023092
178. Wyand, M. S., Manson, K. H., Garcia-Moll, M., Montefiori, D., and Desrosiers, R. C. (1996). Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J. Virol. 70, 3724-3733. doi: 10.1038/nm0197-32
179. Yap, M. W., Nisole, S., Lynch, C., and Stoye, J. P. (2004). Trim5alpha protein restricts both HIV-1 and murine leukemia virus. Proc. Nat. Acad. Sci. U.S.A. 101, 10786-10791. doi: 10.1073/pnas.0402876101
180. Ylinen, L. M., Price, A. J., Rasaiyaah, J., Hue, S., Rose, N. J., Marzetta, F., et al. (2010). Conformational adaptation of Asian macaque TRIMCyp directs lineage specific antiviral activity. PLoS Pathog. 6, e1001062. doi: 10.1371/journal.ppat.1001062
181. Zennou, V., and Bieniasz, P. D. (2006). Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates. Virology 349, 31-40. doi: 10.1016/j.virol.2005.12.035
182. Zhang, F., Wilson, S. J., Landford, W. C., Virgen, B., Gregory, D., Johnson, M. C., et al. (2009). Nef proteins from simian immunodeficiency viruses are tetherin antagonists. Cell Host Microbe 6, 54-67. doi: 10.1016/j.chom.2009.05.008
183. Zhao, C., Collins, M. N., Hsiang, T. Y., and Krug, R. M. (2013). Interferon-induced ISG15 pathway: an ongoing virus-host battle. Trends Microbiol. 21, 181-186. doi: 10.1016/j.tim.2013.01.005
184. Zheng, Y. H., Irwin, D., Kurosu, T., Tokunaga, K., Sata, T., and Peterlin, B. M. (2004). Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication. J. Virol. 78, 6073-6076. doi: 10.1128/JVI.78.11.6073-6076.2004